SGLT2 Versus GLP1 for Cardiovascular Prevention

Annals on Call

In this episode of Annals On Call, Dr. Centor discusses the use of sodium–glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes with Dr. Elisabetta Patorno.

First, listen to the podcast. After listening, ACP members can take the CME/MOC quiz for free.


Up to 1 AMA PRA Category 1 Credits ™ and MOC Points
Expires December 21, 2024   active


Free to Members


Podcasts and Audio Content


Annals on Call

Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.